• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.24% Nasdaq Up 1.32%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    2.86 Up 0.07(2.51%) 1:01PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.79
    Open:2.85
    Bid:2.85 x 1500
    Ask:2.86 x 1000
    1y Target Est:6.50
    Beta:2.24596
    Earnings Date:Nov 5 - Nov 9 (Est.)
    Day's Range:2.79 - 2.95
    52wk Range:1.94 - 5.48
    Volume:323,380
    Avg Vol (3m):1,658,850
    Market Cap:337.83M
    P/E (ttm):N/A
    EPS (ttm):-0.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IDRAUp 2.51%337.83M
    DVAXUp 4.19%1.08B
    PFEUp 0.81%194.98B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4,641.70
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.46
    Quarterly EPS Est (Sep-15) :-0.11
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback